Market closed

Fresenius Medical Care AG/€FME

08:00

10:10

12:15

14:25

16:30

1D1W1MYTD1Y5YMAX

About Fresenius Medical Care AG

Fresenius Medical Care, listed under the ticker FME, is a global provider of dialysis services and products for individuals diagnosed with chronic kidney failure. Founded in 1996 and headquartered in Bad Homburg, Germany, the company operates in the healthcare sector. Beyond dialysis, Fresenius Medical Care offers a range of other services, including hospital management and related healthcare services, advancing its position as a comprehensive healthcare provider internationally.

Ticker

€FME

Sector

Health Care

Trading on

XETRA

Industry

Health Care Providers & Services

Headquarters

Bad Homburg, Germany

Employees

113,079

Website

www.freseniusmedicalcare.com

FME Metrics

BasicAdvanced

€13B

19.23 €2.25

0.85 €1.19

2.76%

Price and volume

Market cap

€13B

Beta

0.85

52-week high

€45.69

52-week low

€32.51

Average daily volume

495K

Dividend rate

€1.19

Financial strength

Current ratio

1.374

Quick ratio

0.784

Long term debt to equity

64.622

Total debt to equity

75.906

Dividend payout ratio (TTM)

52.99%

Interest coverage (TTM)

4.33%

Management effectiveness

Return on assets (TTM)

2.98%

Return on equity (TTM)

5.82%

Valuation

Price to earnings (TTM)

19.23

Price to revenue (TTM)

0.659

Price to book

0.86

Price to tangible book (TTM)

-17.09

Price to free cash flow (TTM)

8.239

Dividend yield (TTM)

2.76%

Forward dividend yield

2.76%

Growth

Revenue change (TTM)

-1.15%

Earnings per share change (TTM)

46.47%

3-year revenue growth (CAGR)

3.46%

3-year earnings per share growth (CAGR)

-10.51%

3-year dividend per share growth (CAGR)

-3.88%

What the Analysts think about FME

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Fresenius Medical Care AG stock.

FME Financial Performance

Income Statement

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37B

-39.75%

Net income

$45B

107.52%

Profit margin

37.65%

6.78%

FME Earnings Performance

Earnings per share (EPS)

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Market data provided by CBOE Europe

Buy €FME

€

Capital at risk

Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Fresenius Medical Care AG stock?

Fresenius Medical Care AG (FME) has a market cap of €13B as of January 15, 2025.

What is the P/E ratio for Fresenius Medical Care AG stock?

The price to earnings (P/E) ratio for Fresenius Medical Care AG (FME) stock is 19.23 as of January 15, 2025.

Does Fresenius Medical Care AG stock pay dividends?

Yes, the Fresenius Medical Care AG (FME) stock pays dividends to shareholders. As of January 15, 2025, the dividend rate is €1.19 and the yield is 2.76%. Fresenius Medical Care AG has a payout ratio of 52.99% on a trailing twelve-month basis.

When is the next Fresenius Medical Care AG dividend payment date?

The next Fresenius Medical Care AG (FME) dividend payment date is unconfirmed.

What is the beta indicator for Fresenius Medical Care AG?

Fresenius Medical Care AG (FME) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.